Format

Send to

Choose Destination

Prospective Assessment of an innovative test for prostate cancer screening using the VITA process model framework.

Author information

1
Medical Informatics of the Friedrich-Alexander-University Erlangen-Nuremberg, Erlangen, Germany.
2
Health Management of the Friedrich-Alexander-University Erlangen-Nuremberg, Erlangen, Germany.
3
Interdisciplinary Centre for Public Health of the Friedrich-Alexander-University Erlangen-Nuremberg, Erlangen, Germany.
4
Computer Networks and Communication Systems of the Friedrich-Alexander-University Erlangen-Nuremberg, Erlangen, Germany.
5
sepp.med GmbH, Röttenbach, Germany.
6
Siemens Healthcare Consulting, Siemens AG, Erlangen, Germany.

Abstract

Healthcare innovations are crucial for enhancing patient treatment and a high-quality healthcare system. However, bringing new technologies, methods and procedures into the healthcare market is challenging. Enormous amounts of financial, personnel and organizational resources are required with no upfront certainty for the medical and economic benefit. A new and innovative approach uses interdisciplinary medical, technical and economic expertise to forecast effects of healthcare innovations already at the early research and concept phase of an idea and before major investments are made. A process model framework was developed to operationalize this structured assessment of healthcare innovations. The Visionary Iterative Tailored Approach (VITA) is based on conceptual modeling, simulation and health economics evaluation. Its application for the prospective assessment of an innovative prostate cancer screening is presented.

PMID:
25160181
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for IOS Press
Loading ...
Support Center